CI Investments Inc
ELGX

CI Investments Inc’s Endologix Inc ELGX Stock Holding History

CI Investments Inc’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-130,000
Closed -$859K – 360
2019
Q1 		$859K Buy
+130,000
New +$857K ﹤0.01% 289

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

CI Investments Inc's ELGX Position: Q2 2019 in Review

CI Investments Inc sold out of Endologix Inc (ELGX) in Q2 2019, closing a stake of 130,000 shares — an estimated $859K sold.

CI Investments Inc first reported a position in ELGX in Q1 2019 and held it in 1 quarter. The position peaked at $859K in Q1 2019. 75 funds tracked by Wall St. Rank hold ELGX as of Q2 2019.

  • CI Investments Inc reported no remaining Endologix Inc position as of Q2 2019 after selling out during the quarter.
  • CI Investments Inc sold 130,000 Endologix Inc shares in Q2 2019, an estimated $859K.
  • CI Investments Inc first reported a position in Endologix Inc in Q1 2019 and held it in 1 quarter.
  • CI Investments Inc's Endologix Inc position peaked at $859K in Q1 2019.
  • 75 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2019.

Based on CI Investments Inc's 13F filing for Q2 2019, filed 12 Aug 2019.